These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38880873)

  • 41. European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
    Lawler M; Davies L; Oberst S; Oliver K; Eggermont A; Schmutz A; La Vecchia C; Allemani C; Lievens Y; Naredi P; Cufer T; Aggarwal A; Aapro M; Apostolidis K; Baird AM; Cardoso F; Charalambous A; Coleman MP; Costa A; Crul M; Dégi CL; Di Nicolantonio F; Erdem S; Geanta M; Geissler J; Jassem J; Jagielska B; Jonsson B; Kelly D; Kelm O; Kolarova T; Kutluk T; Lewison G; Meunier F; Pelouchova J; Philip T; Price R; Rau B; Rubio IT; Selby P; Južnič Sotlar M; Spurrier-Bernard G; van Hoeve JC; Vrdoljak E; Westerhuis W; Wojciechowska U; Sullivan R
    Lancet Oncol; 2023 Jan; 24(1):e11-e56. PubMed ID: 36400101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
    Banerjee S; Farina N; Henderson C; High J; Stirling S; Shepstone L; Fountain J; Ballard C; Bentham P; Burns A; Fox C; Francis P; Howard R; Knapp M; Leroi I; Livingston G; Nilforooshan R; Nurock S; O'Brien J; Price A; Thomas AJ; Swart AM; Telling T; Tabet N
    Health Technol Assess; 2023 Oct; 27(23):1-108. PubMed ID: 37929672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling technology innovation: how science, engineering, and industry methods can combine to generate beneficial socioeconomic impacts.
    Stone VI; Lane JP
    Implement Sci; 2012 May; 7():44. PubMed ID: 22591638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Establishing ophthalmology in the research framework programs of the European Union].
    Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
    Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.
    Coebergh JW; van den Hurk C; Rosso S; Comber H; Storm H; Zanetti R; Sacchetto L; Janssen-Heijnen M; Thong M; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):997-1017. PubMed ID: 25956208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study.
    Vaccarella S; Georges D; Bray F; Ginsburg O; Charvat H; Martikainen P; Brønnum-Hansen H; Deboosere P; Bopp M; Leinsalu M; Artnik B; Lorenzoni V; De Vries E; Marmot M; Vineis P; Mackenbach J; Nusselder W
    Lancet Reg Health Eur; 2023 Feb; 25():100551. PubMed ID: 36818237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany.
    Kusch M; Labouvie H; Schiewer V; Talalaev N; Cwik JC; Bussmann S; Vaganian L; Gerlach AL; Dresen A; Cecon N; Salm S; Krieger T; Pfaff H; Lemmen C; Derendorf L; Stock S; Samel C; Hagemeier A; Hellmich M; Leicher B; Hültenschmidt G; Swoboda J; Haas P; Arning A; Göttel A; Schwickerath K; Graeven U; Houwaart S; Kerek-Bodden H; Krebs S; Muth C; Hecker C; Reiser M; Mauch C; Benner J; Schmidt G; Karlowsky C; Vimalanandan G; Matyschik L; Galonska L; Francke A; Osborne K; Nestle U; Bäumer M; Schmitz K; Wolf J; Hallek M
    BMC Health Serv Res; 2022 Apr; 22(1):543. PubMed ID: 35459202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
    Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
    EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shaping science policy in Europe.
    Celis JE; Gago JM
    Mol Oncol; 2014 May; 8(3):447-57. PubMed ID: 24726457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study.
    You J; Zhang YR; Wang HF; Yang M; Feng JF; Yu JT; Cheng W
    EClinicalMedicine; 2022 Nov; 53():101665. PubMed ID: 36187723
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.